skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Recently, Informa Pharma Intelligence conduced an insightful webinar regarding the current market landscape and outlook for immuno-oncology, one of the fastest-growing and most complex markets for pharma.

 

 

PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology is a comprehensive look at the immuno-oncology landscape, and includes:

  • An overview of the current immuno-oncology market
  • Ongoing developments in the PD-1/PD-L1 therapy space
  • Challenges with PD-1/PD-L1 inhibitor development and treatment
  • An examination of:
    • Non-small cell lung cancer (NSCLC)
    • Bladder cancer
  • A look at the future of immuno-oncology

Watch webinar recording here

 

 

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: